Keyphrases
Autograft
100%
Single-center Study
100%
High-dose Melphalan
100%
Disease Progression
66%
Myeloma
66%
β2-microglobulin (β2-MG)
66%
Marrow
33%
Doxorubicin
33%
Royal
33%
Overall Response Rate
33%
Interferon-α (IFN-α)
33%
Filgrastim
33%
Complete Remission
33%
Blood Stem Cells
33%
Albumin
33%
Near-complete
33%
Excellent Outcome
33%
Melphalan
33%
Autotransplantation
33%
Previously Untreated
33%
Stem Cell Harvest
33%
Cox Analysis
33%
Sequence of Therapy
33%
Transplant Toxicity
33%
Medicine and Dentistry
Drug Megadose
100%
Autograft
100%
Melphalan
100%
Disease Exacerbation
66%
Myeloma
66%
Albumin
33%
Vincristine
33%
Stem Cell
33%
Event Free Survival
33%
Autotransplantation
33%
Doxorubicin
33%
Interferon
33%
Filgrastim
33%
Immunology and Microbiology
Autograft
100%
Drug Megadose
100%
Interferon Type I
33%
Stem Cell
33%
Event Free Survival
33%
Filgrastim
33%
Autotransplantation
33%
Albumin
33%